TREMFYA (guselkumab) Gets Positive CHMP Opinion for Crohn’s Disease
March 28, 2025
Recommendation based on the findings from the Phase 3 studies (GALAXI programme and GRAVITI) in Crohn’s disease Johnson & Johnson announced that the Committee for